Intervention Review

Teriflunomide for multiple sclerosis

  1. Dian He1,
  2. Zhu Xu1,
  3. Shuai Dong2,
  4. Hong Zhang3,
  5. Hongyu Zhou4,*,
  6. Lu Wang4,
  7. Shihong Zhang4

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 12 DEC 2012

Assessed as up-to-date: 7 AUG 2012

DOI: 10.1002/14651858.CD009882.pub2

How to Cite

He D, Xu Z, Dong S, Zhang H, Zhou H, Wang L, Zhang S. Teriflunomide for multiple sclerosis. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD009882. DOI: 10.1002/14651858.CD009882.pub2.

Author Information

  1. 1

    Affiliated Hospital of Guiyang Medical College, Department of Neurology, Guiyang, Guizhou Province, China

  2. 2

    Jinan No. 6 People's Hospital, Department of Neurology, Jinan, Shandong Province, China

  3. 3

    Jinan No. 6 People's Hospital, Clinical Laboratory, Jinan, Shandong Province, China

  4. 4

    West China Hospital, Sichuan University, Department of Neurology, Chengdu, Sichuan, China

*Hongyu Zhou, Department of Neurology, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. Hyzhou98@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH